Name	Pidotimod
Description	Pidotimod is a synthetic dipeptide with immunomodulatory properties.
In vitro	Pidotimod is a synthetic dipeptide molecule with biological and immunological activity on both the adaptive and the innate immune responses. In vitro studies, both from animal and human specimens, have documented a good activity on innate and adaptive immune responses and have been confirmed by in vivo studies. These activities have been applied in clinical studies demonstrating the efficacy of pidotimod in reducing the rate of recurrent infections of the upper respiratory and urinary tracts in children. The same results are obtained in recurrent respiratory tract infections in adults.
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 50 mg/mL (204.69 mM), Sonication is recommended. H2O : 10 mg/mL (40.93 mM)
Keywords	COPD \| obstructive pulmonary disease \| Inhibitor \| Bacterial \| bronchiectasis \| Pidotimod \| chronic bronchitis \| inhibit \| idiopathic urticaria
Inhibitors Related	Neomycin sulfate \| Sulfamethoxazole sodium \| Dimethyl sulfoxide
Related Compound Libraries	Nonsteroidal Anti-Inflammatory Compound Library \| FDA-Approved & Pharmacopeia Drug Library \| Bioactive Compound Library \| Drug Repurposing Compound Library \| Anti-Bacterial Compound Library \| Orally Active Compound Library \| Bioactive Compounds Library Max \| Anti-Infection Compound Library

Pidotimod NEW

Product Introduction